Burrows Scott L

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
7
Insider Sells Sum
$1.07M

Insider Activity of Burrows Scott L

According to the SEC Form 4 filings, Burrows Scott L, being in a position of

  1. Chief Financial Officer at Spyre Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 18531 share for $522,074,
    over all time since 2024-09-03, has bought 0 shares, and sold 18531 share for $522,074.

The largest sale of all time was on 2024-09-03 and amounted to 18531 share of Spyre Therapeutics, Inc. for $522,074.

Biography of Burrows Scott L

No biography is available at this moment.

2024-09-03SaleSpyre Therapeutics, Inc.
SYRE
Chief Financial Officer
18,531
0.0313%
$28.17$522,074+7.48%
2023-03-06SaleArcutis Biotherapeutics, Inc.
ARQT
Chief Financial Officer
291
0.0005%
$15.26$4,442-43.54%
2023-03-02SaleArcutis Biotherapeutics, Inc.
ARQT
Chief Financial Officer
1,434
0.0023%
$15.83$22,696-48.14%
2023-02-28SaleArcutis Biotherapeutics, Inc.
ARQT
Chief Financial Officer
416
0.0007%
$16.17$6,725-49.29%
2022-03-03SaleArcutis Biotherapeutics, Inc.
ARQT
Chief Financial Officer
10
<0.0001%
$16.44$164+6.62%
2022-03-01SaleArcutis Biotherapeutics, Inc.
ARQT
Chief Financial Officer
420
0.0008%
$17.75$7,456+7.66%
2021-12-27SaleArcutis Biotherapeutics, Inc.
ARQT
Chief Financial Officer
25,120
0.0497%
$20.07$504,279-5.19%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.